Publication | Open Access

Heavy menstrual bleeding in women treated with rivaroxaban and vitamin K antagonists and the risk of recurrent venous thromboembolism

Vitamin K AntagonistsThrombosisVenous ThrombosisCardiovascular DiseaseMedicineGynecologyRecurrent Venous ThromboembolismPharmacotherapyCoagulopathyBleeding DisorderPharmacologyAnticoagulantAtherosclerosisHeavy Menstrual BleedingWomen's Health